Related Experiment Video
Updated: Sep 29, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and
James R Jabbur1, Amy D Tabor, Xiaodong Cheng
1Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, TX 77030, USA.
Abstract:
Analyses of five wild-type p53 containing cell lines revealed lineage specific differences in phosphorylation of Thr18 after treatment with ionizing (IR) or ultraviolet (UV) radiation. Importantly, Thr18 phosphorylation correlated with induction of the p53 downstream targets p21(Waf1/Cip1) (p21) and Mdm-2, suggesting a transactivation enhancing role. Thr18 phosphorylation has been shown to abolish side-chain hydrogen bonding between Thr18 and Asp21, an interaction necessary for stabilizing alpha-helical conformation within the transactivation domain. Mutagenesis-derived hydrogen bond disruption attenuated the interaction of p53 with the transactivation repressor Mdm-2 but had no direct effect on the interaction of p53 with the basal transcription factor TAF(II)31. However, prior incubation of p53 mutants with Mdm-2 modulated TAF(II)31 interaction with p53, suggesting Mdm-2 blocks the accessibility of p53 to TAF(II)31. Consistently, p53-null cells transfected with hydrogen bond disrupting p53 mutants demonstrated enhanced endogenous p21 expression, whereas p53/Mdm-2-double null cells exhibited no discernible differences in p21 expression. We conclude disruption of intramolecular hydrogen bonding between Thr18 and Asp21 enhances p53 transactivation by modulating Mdm-2 binding, facilitating TAF(II)31 recruitment.
Insights
Phosphorylation of Thr18 in p53 protein enhances its tumor suppressor activity by disrupting Mdm-2 binding, leading to increased p21 expression. This finding is crucial for understanding p53’s role in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage.
- Post-translational modifications, such as phosphorylation, regulate p53 activity and stability.
- Specific phosphorylation sites, like Thr18, are implicated in modulating p53's transactivation function.
Purpose of the Study:
- To investigate the role of Thr18 phosphorylation in p53 transactivation.
- To elucidate the mechanism by which Thr18 phosphorylation affects p53 interactions with Mdm-2 and TAFII31.
- To determine the functional consequence of disrupting the Thr18-Asp21 hydrogen bond on p53-mediated gene expression.
Main Methods:
- Analysis of p53 phosphorylation in wild-type cell lines after ionizing (IR) and ultraviolet (UV) radiation.
- Site-directed mutagenesis to disrupt the hydrogen bond between Thr18 and Asp21.
- Co-immunoprecipitation assays to assess protein-protein interactions (p53-Mdm-2, p53-TAFII31).
- Transfection studies in p53-null and p53/Mdm-2-double null cells to evaluate p21 induction.
Main Results:
- Thr18 phosphorylation in p53 correlated with the induction of downstream targets p21(Waf1/Cip1) (p21) and Mdm-2.
- Disruption of the Thr18-Asp21 hydrogen bond attenuated p53 interaction with Mdm-2 but not TAFII31.
- Mdm-2 was shown to inhibit p53 interaction with TAFII31.
- p53-null cells expressing Thr18-Asp21 hydrogen bond disrupting mutants showed enhanced p21 expression.
Conclusions:
- Disruption of the intramolecular hydrogen bond between Thr18 and Asp21 enhances p53 transactivation.
- This enhancement is mediated by modulating Mdm-2 binding, which facilitates TAFII31 recruitment.
- The findings provide a mechanistic insight into how p53 activity is regulated post-translationally for tumor suppression.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Master Transcription Regulators
Negative Regulator Molecules
